Fortress Biotech News

Latest Fortress Biotech Stock News & FBIOP Headlines

Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends?

6 months ago | seekingalpha.com

Fortress Biotech to Participate in A.G.P.'s Annual Virtual Healthcare Conference

6 months ago | globenewswire.com

Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

6 months ago | globenewswire.com

Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

6 months ago | globenewswire.com

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights

7 months ago | globenewswire.com

Fortress Biotech (NASDAQ:FBIOP) Stock Price Up 22.9% – Here’s What Happened

9 months ago | defenseworld.net

UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

9 months ago | globenewswire.com

Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

9 months ago | globenewswire.com

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States

10 months ago | globenewswire.com

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

a year ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

FBIOP

Fortress Biotech

$ 14.36

-4.27%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated a day ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Fortress Biotech News

Latest Fortress Biotech Stock News & FBIOP Headlines

Download App

People Also Watch

Explore our Tools